Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis

Arthritis & Rheumatism

Volumn 31, Issue 5, 1988, Pages 632-641

  Hopkins, Patricia ^a   Michael Belmont, H ^a   Buyon, Jill ^a   Philips, Mark ^a   Weissmann, Gerald ^a   Abramson, Steven B ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A;

CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; DISEASE ACTIVITY; FEMALE; HISTOLOGY; HUMAN; PREGNANCY; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ANAPHYLATOXINS; BRAIN; COMPLEMENT 3; COMPLEMENT 3A; COMPLEMENT 5; COMPLEMENT 5A; ENCEPHALITIS; FEMALE; FORECASTING; HUMAN; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; SUPPORT, U.S. GOV'T, P.H.S.; VASCULAR DISEASES;

EID: 0023888694     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780310508     Document Type: Article

References (39)

1. The spectrum of vasculitis
2. Significance of serum complement levels for diagnosis and prognosis of acute and subacute glomerulonephritis and lupus erythematosus disseminatus
3. Immunological factors and clinical activity in systemic lupus erythematosus
4. Human complement metabolism: an analysis of 144 studies
5. Studies of the in vitro behavior of human C3 in normal subjects and patients
6. Decreased synthesis of the third component (C3) in hypocomplementemic systemic lupus erythematosus
7. Metabolic studies of the third component of complement and the glycine rich glyco‐protein in patients with hypocomplementemia
8. Complement activation during systemic lupus erythematosus: C3a and C5a anaphylatoxins circulate during exacerlations of disease
9. Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus
10. The correlation between SLE and disease activity, complement components, and complement activation products (abstract)
11. The 1982 revised criteria for the classification of systemic lupus erythematosus
12. Complement activation during cardiopulmonary bypass
13. Immunochemical quantitation of antigens by single radial immunodiffusion
14. The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus
15. Systemic lupus erythematosus in childhood: correlations between changes in disease activity and serum complement levels
16. Circulating immune complexes in systemic lupus erythematosus
17. Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus
18. The value of three immune complex assays in the management of systemic lupus erythematosus: an assessment of immune complex levels, size, and immunochemical properties in relation to disease activity and manifestation
19. The C1q binding assay in systemic lupus erythematosus: discordance with disease activity
20. Useful laboratory measurements in the management of systemic lupus erythematosus
21. Specific detection of circulating DNA:anti‐DNA immune complexes in human systemic lupus erythematosus sera using murine monoclonal anti‐DNA antibody
22. Metabolism of the third complement component (C3) in nephritis
23. Lupus pregnancy. II. Unusual pattern of hypocomplementemia and thrombocytopenia in the pregnant patient
24. C3a induced lysosomal enzyme secretion from human neutrophils
25. Human platelet activation by C3a and C3a des arg
26. Chemotactic response to human C3a and C5a anaphylatoxins
27. Microvascular effects of anaphylatoxins C3a and C5a
28. Analysis of the binding of flourescent C5a and C3a to human peripheral blood leukocytes
29. Increased expression of an adhesion‐promoting surface glycoprotein in the granulocytopenia of hemodialysis
30. Neutrophil activation in thermal injury as assessed by increased expression of complement expression
31. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955–1977
32. The neurological manifestations of systemic lupus erythematosus: a clinical pathological study of 24 cases and a review of the literature
33. Severe retinal vaso‐occlusive disease in systemic lupus erythematosus
34. Sudden blindness in acute pancreatitis of complement‐induced retinal leukoembolization
35. Complement‐induced granulocyte aggregation: an unsuspected mechanism of disease
36. Association of complement activation and elevated plasma C5a with adult respiratory distress syndrome
37. An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor‐α' increases neutrophil adherence by a CDw18‐dependent mechanism